Mindray Medical International
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Mindray Medical International beat expectations on revenues and crushed expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share increased significantly. GAAP earnings per share increased significantly.
Gross margins increased, operating margins grew, net margins were steady.
Mindray Medical International logged revenue of $316.1 million. The six analysts polled by S&P Capital IQ expected revenue of $307.2 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $264.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.51. The three earnings estimates compiled by S&P Capital IQ averaged $0.39 per share. Non-GAAP EPS of $0.51 for Q4 were 16% higher than the prior-year quarter's $0.44 per share. GAAP EPS of $0.47 for Q4 were 18% higher than the prior-year quarter's $0.40 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 57.8%, 360 basis points better than the prior-year quarter. Operating margin was 18.9%, 80 basis points better than the prior-year quarter. Net margin was 17.7%, much about the same as the prior-year quarter.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,347 members out of 1,381 rating the stock outperform, and 34 members rating it underperform. Among 285 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 273 give Mindray Medical International a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mindray Medical International is outperform, with an average price target of $36.43.
Is Mindray Medical International the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Mindray Medical International to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.